iSpecimen trades near lows as cash test and vote loom
iSpecimen Inc. was down in quiet pre-market action Friday, hovering close to its lows after a reverse stock split. Investors waited for the next shareholder meeting and kept an eye on the company’s soft cash and revenue numbers as the biospecimen marketplace worked to steady itself. iSpecimen is pushing ahead with its 2025 annual meeting, according to a recent regulatory filing. The meeting, delayed multiple times for lack of quorum, is now scheduled to pick up again May 29 at 9:00 a.m. Eastern. The company said none of the proposals up for a vote have changed.